id | C00000555 |
---|---|
Name | Emodin |
CAS RN | 518-82-1 |
Standard InChI | InChI=1S/C15H10O5/c1-6-2-8-12(10(17)3-6)15(20)13-9(14(8)19)4-7(16)5-11(13)18/h2-5,16-18H,1H3 |
Standard InChI (Main Layer) | InChI=1S/C15H10O5/c1-6-2-8-12(10(17)3-6)15(20)13-9(14(8)19)4-7(16)5-11(13)18/h2-5,16-18H,1H3 |
Phytochemical cluster | No. 62 |
---|---|
KCF-S cluster | No. 41 |
By standard InChI | CHEMBL289277 |
---|---|
By standard InChI Main Layer | CHEMBL289277 |
By LinkDB | C10343 |
---|
By CAS RN | D004642 |
---|
class name | count |
---|---|
rosids | 32 |
eudicotyledons | 6 |
Liliopsida | 2 |
asterids | 1 |
family name | count |
---|---|
Fabaceae | 23 |
Polygonaceae | 5 |
Rhamnaceae | 4 |
Hypericaceae | 3 |
Picramniaceae | 2 |
Chaetomiaceae | 1 |
Zingiberaceae | 1 |
Lardizabalaceae | 1 |
Aspergillaceae | 1 |
Phaeosphaeriaceae | 1 |
accession | description | class description | compound | assay ID (# of activities) |
# of diseases
(OMIM / KEGG) |
---|---|---|---|---|---|
P10635 | Cytochrome P450 2D6 | Cytochrome P450 2D6 | CHEMBL289277 |
CHEMBL1614110
(2)
|
1 / 0 |
Q02750 | Dual specificity mitogen-activated protein kinase kinase 1 | Ste7 | CHEMBL289277 |
CHEMBL1063679
(1)
|
1 / 1 |
P22310 | UDP-glucuronosyltransferase 1-4 | Enzyme | CHEMBL289277 |
CHEMBL1908081
(1)
CHEMBL1908082
(1)
|
3 / 0 |
P04637 | Cellular tumor antigen p53 | Transcription Factor | CHEMBL289277 |
CHEMBL1613992
(1)
CHEMBL1613995
(1)
CHEMBL2114895 (2) |
7 / 44 |
Q9HAW8 | UDP-glucuronosyltransferase 1-10 | Enzyme | CHEMBL289277 |
CHEMBL1908087
(1)
|
0 / 0 |
P49798 | Regulator of G-protein signaling 4 | Unclassified protein | CHEMBL289277 |
CHEMBL1794499
(1)
|
2 / 0 |
Q12809 | Potassium voltage-gated channel subfamily H member 2 | KCNH, Kv10-12.x (Ether-a-go-go) | CHEMBL289277 |
CHEMBL1794573
(1)
|
2 / 2 |
P08246 | Neutrophil elastase | S1A | CHEMBL289277 |
CHEMBL873592
(1)
CHEMBL674382
(1)
|
2 / 1 |
Q15759 | Mitogen-activated protein kinase 11 | p38 | CHEMBL289277 |
CHEMBL1061119
(1)
|
0 / 0 |
Q16539 | Mitogen-activated protein kinase 14 | p38 | CHEMBL289277 |
CHEMBL1063691
(1)
|
0 / 0 |
P06746 | DNA polymerase beta | Enzyme | CHEMBL289277 |
CHEMBL1614079
(1)
|
0 / 0 |
O15530 | 3-phosphoinositide-dependent protein kinase 1 | Pdk1 | CHEMBL289277 |
CHEMBL1052131
(1)
|
0 / 0 |
P41240 | Tyrosine-protein kinase CSK | Csk | CHEMBL289277 |
CHEMBL1061124
(1)
|
0 / 0 |
P42336 | Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | Enzyme | CHEMBL289277 |
CHEMBL1942592
(1)
CHEMBL1942596
(1)
|
9 / 1 |
P17252 | Protein kinase C alpha type | Alpha | CHEMBL289277 |
CHEMBL1063681
(1)
|
0 / 0 |
Q03181 | Peroxisome proliferator-activated receptor delta | NR1C2 | CHEMBL289277 |
CHEMBL1794524
(2)
CHEMBL1794552
(2)
|
0 / 0 |
Q13526 | Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | Enzyme | CHEMBL289277 |
CHEMBL1794585
(1)
|
0 / 0 |
O14757 | Serine/threonine-protein kinase Chk1 | Chk1 | CHEMBL289277 |
CHEMBL1051273
(1)
|
0 / 0 |
P02545 | Prelamin-A/C | Unclassified protein | CHEMBL289277 |
CHEMBL1614544
(1)
|
11 / 10 |
P16473 | Thyrotropin receptor | Glycohormone receptor | CHEMBL289277 |
CHEMBL1614281
(3)
CHEMBL1614361
(3)
|
3 / 2 |
P10828 | Thyroid hormone receptor beta | NR1A2 | CHEMBL289277 |
CHEMBL1613776
(1)
|
3 / 1 |
P19793 | Retinoic acid receptor RXR-alpha | NR2B1 | CHEMBL289277 |
CHEMBL1794371
(1)
|
0 / 0 |
P68400 | Casein kinase II subunit alpha | Ck2 | CHEMBL289277 |
CHEMBL974405
(1)
CHEMBL1062826
(1)
CHEMBL1063784 (1) CHEMBL1061117 (1) CHEMBL1063677 (1) |
0 / 0 |
P24941 | Cyclin-dependent kinase 2 | Cdc2 | CHEMBL289277 |
CHEMBL1063693
(1)
|
0 / 0 |
P11712 | Cytochrome P450 2C9 | Cytochrome P450 2C9 | CHEMBL289277 |
CHEMBL1614027
(2)
|
0 / 1 |
P23443 | Ribosomal protein S6 kinase beta-1 | p70 | CHEMBL289277 |
CHEMBL1060172
(1)
|
0 / 0 |
P54132 | Bloom syndrome protein | Enzyme | CHEMBL289277 |
CHEMBL1614522
(1)
CHEMBL1614067
(1)
|
1 / 2 |
Q9NR56 | Muscleblind-like protein 1 | Unclassified protein | CHEMBL289277 |
CHEMBL1614166
(1)
|
1 / 0 |
P15311 | Ezrin | Unclassified protein | CHEMBL289277 |
CHEMBL1937278
(1)
|
0 / 1 |
P11473 | Vitamin D3 receptor | NR1I1 | CHEMBL289277 |
CHEMBL1794311
(1)
CHEMBL1794376
(1)
CHEMBL1794339 (1) |
2 / 3 |
O75582 | Ribosomal protein S6 kinase alpha-5 | CAMK serine/threonine protein kinase MSKB subfamily | CHEMBL289277 |
CHEMBL1063680
(1)
|
0 / 0 |
Q9Y3R4 | Sialidase-2 | Enzyme | CHEMBL289277 |
CHEMBL1100507
(1)
|
0 / 0 |
P00352 | Retinal dehydrogenase 1 | Enzyme | CHEMBL289277 |
CHEMBL1614458
(3)
|
0 / 0 |
Q16665 | Hypoxia-inducible factor 1-alpha | Transcription Factor | CHEMBL289277 |
CHEMBL1614456
(1)
CHEMBL1613803
(1)
|
0 / 0 |
P09769 | Tyrosine-protein kinase Fgr | Src | CHEMBL289277 |
CHEMBL1051346
(1)
|
0 / 0 |
P39748 | Flap endonuclease 1 | Enzyme | CHEMBL289277 |
CHEMBL1613922
(1)
CHEMBL1794486
(2)
|
0 / 0 |
O75496 | Geminin | Unclassified protein | CHEMBL289277 |
CHEMBL1613941
(1)
CHEMBL2114843
(1)
CHEMBL2114780 (1) |
0 / 0 |
O60656 | UDP-glucuronosyltransferase 1-9 | Enzyme | CHEMBL289277 |
CHEMBL1908086
(1)
|
0 / 0 |
P54855 | UDP-glucuronosyltransferase 2B15 | Enzyme | CHEMBL289277 |
CHEMBL1908090
(1)
|
0 / 0 |
Q92731 | Estrogen receptor beta | NR3A2 | CHEMBL289277 |
CHEMBL677051
(1)
CHEMBL677223
(1)
CHEMBL708330 (1) CHEMBL708331 (1) CHEMBL708332 (1) |
0 / 1 |
P10145 | Interleukin-8 | Secreted protein | CHEMBL289277 |
CHEMBL2114835
(1)
|
0 / 0 |
P49841 | Glycogen synthase kinase-3 beta | Gsk | CHEMBL289277 |
CHEMBL1063786
(1)
|
0 / 0 |
P08311 | Cathepsin G | S1A | CHEMBL289277 |
CHEMBL662702
(1)
|
0 / 0 |
Q15418 | Ribosomal protein S6 kinase alpha-1 | Rskb | CHEMBL289277 |
CHEMBL1061120
(1)
|
0 / 0 |
O15264 | Mitogen-activated protein kinase 13 | p38 | CHEMBL289277 |
CHEMBL1060170
(1)
|
0 / 0 |
Q9Y253 | DNA polymerase eta | Enzyme | CHEMBL289277 |
CHEMBL1794569
(1)
|
1 / 1 |
P11308 | Transcriptional regulator ERG | Unclassified protein | CHEMBL289277 |
CHEMBL2114924
(1)
|
1 / 2 |
P83916 | Chromobox protein homolog 1 | Unclassified protein | CHEMBL289277 |
CHEMBL1738610
(1)
CHEMBL1794401
(1)
|
0 / 0 |
Q9HC16 | DNA dC->dU-editing enzyme APOBEC-3G | Enzyme | CHEMBL289277 |
CHEMBL1794342
(1)
|
0 / 0 |
O94782 | Ubiquitin carboxyl-terminal hydrolase 1 | Enzyme | CHEMBL289277 |
CHEMBL1794467
(1)
|
0 / 0 |
P04150 | Glucocorticoid receptor | NR3C1 | CHEMBL289277 |
CHEMBL1794382
(1)
|
0 / 1 |
P37231 | Peroxisome proliferator-activated receptor gamma | NR1C3 | CHEMBL289277 |
CHEMBL1794510
(1)
|
5 / 3 |
Q9H244 | P2Y purinoceptor 12 | Purine receptor | CHEMBL289277 |
CHEMBL995340
(1)
CHEMBL995341
(1)
|
1 / 1 |
P12931 | Proto-oncogene tyrosine-protein kinase Src | Src | CHEMBL289277 |
CHEMBL823239
(1)
CHEMBL823857
(1)
|
0 / 0 |
P49137 | MAP kinase-activated protein kinase 2 | CAMK serine/threonine protein kinase MAPKAPK | CHEMBL289277 |
CHEMBL1062862
(1)
|
0 / 0 |
Q96RI1 | Bile acid receptor | NR1H4 | CHEMBL289277 |
CHEMBL1794437
(1)
|
0 / 0 |
P28482 | Mitogen-activated protein kinase 1 | Erk | CHEMBL289277 |
CHEMBL1052129
(1)
CHEMBL1614521
(1)
CHEMBL1613808 (1) |
0 / 0 |
Q9Y4K4 | Mitogen-activated protein kinase kinase kinase kinase 5 | STE serine/threonine protein kinase KHS subfamily | CHEMBL289277 |
CHEMBL1061122
(1)
|
0 / 0 |
Q99714 | 3-hydroxyacyl-CoA dehydrogenase type-2 | Enzyme | CHEMBL289277 |
CHEMBL1614227
(1)
|
3 / 3 |
O15118 | Niemann-Pick C1 protein | Unclassified protein | CHEMBL289277 |
CHEMBL1614342
(1)
|
1 / 1 |
P51449 | Nuclear receptor ROR-gamma | Nuclear hormone receptor subfamily 1 group F member 3 | CHEMBL289277 |
CHEMBL2114842
(1)
|
0 / 0 |
Q9HAW9 | UDP-glucuronosyltransferase 1-8 | Enzyme | CHEMBL289277 |
CHEMBL1908085
(2)
|
0 / 0 |
P03372 | Estrogen receptor | NR3A1 | CHEMBL289277 |
CHEMBL679893
(1)
CHEMBL682303
(1)
CHEMBL708330 (1) CHEMBL708331 (1) CHEMBL708332 (1) CHEMBL1794364 (2) CHEMBL1794542 (1) |
1 / 1 |
Q8IW41 | MAP kinase-activated protein kinase 5 | CAMK serine/threonine protein kinase MAPKAPK | CHEMBL289277 |
CHEMBL1061121
(1)
|
0 / 0 |
O75116 | Rho-associated protein kinase 2 | Rock | CHEMBL289277 |
CHEMBL1062037
(1)
|
0 / 0 |
P07948 | Tyrosine-protein kinase Lyn | Src | CHEMBL289277 |
CHEMBL1051275
(1)
|
0 / 0 |
P16050 | Arachidonate 15-lipoxygenase | Enzyme | CHEMBL289277 |
CHEMBL1614240
(1)
|
0 / 0 |
P31749 | RAC-alpha serine/threonine-protein kinase | Akt | CHEMBL289277 |
CHEMBL1061152
(1)
|
4 / 1 |
O00141 | Serine/threonine-protein kinase Sgk1 | AGC serine/threonine protein kinase SGK subfamily | CHEMBL289277 |
CHEMBL1060171
(1)
|
0 / 0 |
P33261 | Cytochrome P450 2C19 | Cytochrome P450 2C19 | CHEMBL289277 |
CHEMBL1613777
(2)
|
1 / 1 |
P08684 | Cytochrome P450 3A4 | Cytochrome P450 3A4 | CHEMBL289277 |
CHEMBL1614108
(1)
CHEMBL1613886
(1)
|
0 / 1 |
O75365 | Protein tyrosine phosphatase type IVA 3 | Tyr | CHEMBL289277 |
CHEMBL1937271
(2)
CHEMBL1937272
(2)
CHEMBL1937273 (1) CHEMBL1937275 (2) CHEMBL1937276 (1) CHEMBL1937277 (1) |
0 / 0 |
Q9UNA4 | DNA polymerase iota | Enzyme | CHEMBL289277 |
CHEMBL1794483
(2)
|
0 / 0 |
O75164 | Lysine-specific demethylase 4A | Enzyme | CHEMBL289277 |
CHEMBL1737991
(1)
|
0 / 0 |
P27695 | DNA-(apurinic or apyrimidinic site) lyase | Enzyme | CHEMBL289277 |
CHEMBL1614283
(1)
CHEMBL1614211
(3)
|
0 / 0 |
P22309 | UDP-glucuronosyltransferase 1-1 | Enzyme | CHEMBL289277 |
CHEMBL1908080
(2)
|
5 / 1 |
P10636 | Microtubule-associated protein tau | Unclassified protein | CHEMBL289277 |
CHEMBL1614421
(2)
CHEMBL1614502
(2)
|
4 / 3 |
Q99549 | M-phase phosphoprotein 8 | Unclassified protein | CHEMBL289277 |
CHEMBL1738402
(2)
|
0 / 0 |
P19224 | UDP-glucuronosyltransferase 1-6 | Enzyme | CHEMBL289277 |
CHEMBL1908083
(1)
|
0 / 0 |
Q16236 | Nuclear factor erythroid 2-related factor 2 | Unclassified protein | CHEMBL289277 |
CHEMBL2114890
(2)
|
0 / 0 |
O43451 | Maltase-glucoamylase, intestinal | Hydrolase | CHEMBL289277 |
CHEMBL875450
(1)
|
0 / 0 |
P10275 | Androgen receptor | NR3C4 | CHEMBL289277 |
CHEMBL1794321
(2)
CHEMBL1794560
(1)
|
3 / 4 |
P06239 | Tyrosine-protein kinase Lck | Src | CHEMBL289277 |
CHEMBL941407
(1)
CHEMBL1061123
(1)
|
0 / 1 |
P54646 | 5'-AMP-activated protein kinase catalytic subunit alpha-2 | Ampk | CHEMBL289277 |
CHEMBL1063692
(1)
|
0 / 0 |
P35869 | Aryl hydrocarbon receptor | Transcription Factor | CHEMBL289277 |
CHEMBL2114849
(2)
|
0 / 0 |
P43405 | Tyrosine-protein kinase SYK | Syk | CHEMBL289277 |
CHEMBL1063695
(1)
|
0 / 0 |
Q13627 | Dual specificity tyrosine-phosphorylation-regulated kinase 1A | CMGC dual-specificity kinase DYRK1 | CHEMBL289277 |
CHEMBL1060231
(1)
|
1 / 0 |
P53778 | Mitogen-activated protein kinase 12 | p38 | CHEMBL289277 |
CHEMBL1060169
(1)
|
0 / 0 |
Q9UBT6 | DNA polymerase kappa | Enzyme | CHEMBL289277 |
CHEMBL1794536
(2)
|
0 / 0 |
P40225 | Thrombopoietin | Unclassified protein | CHEMBL289277 |
CHEMBL1614086
(1)
CHEMBL1614034
(1)
|
1 / 1 |
Q96KQ7 | Histone-lysine N-methyltransferase EHMT2 | Enzyme | CHEMBL289277 |
CHEMBL1738442
(2)
|
0 / 0 |
Q9NUW8 | Tyrosyl-DNA phosphodiesterase 1 | Enzyme | CHEMBL289277 |
CHEMBL1614364
(3)
|
1 / 1 |
O00255 | Menin | Unclassified protein | CHEMBL289277 |
CHEMBL1614257
(1)
CHEMBL1614531
(1)
|
2 / 5 |
Q03164 | Histone-lysine N-methyltransferase 2A | Enzyme | CHEMBL289277 |
CHEMBL1614257
(1)
CHEMBL1614531
(1)
|
1 / 3 |
Q13951 | Core-binding factor subunit beta | Unclassified protein | CHEMBL289277 |
CHEMBL1613933
(2)
|
0 / 1 |
Q01196 | Runt-related transcription factor 1 | Unclassified protein | CHEMBL289277 |
CHEMBL1613933
(2)
|
1 / 6 |
P45983 | Mitogen-activated protein kinase 8 | Jnk | CHEMBL289277 |
CHEMBL1061151
(1)
|
0 / 0 |
P53779 | Mitogen-activated protein kinase 10 | Jnk | CHEMBL289277 |
CHEMBL1061151
(1)
|
0 / 1 |
P45984 | Mitogen-activated protein kinase 9 | Jnk | CHEMBL289277 |
CHEMBL1061151
(1)
|
0 / 0 |
P22694 | cAMP-dependent protein kinase catalytic subunit beta | Pka | CHEMBL289277 |
CHEMBL1052130
(1)
|
0 / 0 |
P17612 | cAMP-dependent protein kinase catalytic subunit alpha | Pka | CHEMBL289277 |
CHEMBL1052130
(1)
|
0 / 0 |
P22612 | cAMP-dependent protein kinase catalytic subunit gamma | Pka | CHEMBL289277 |
CHEMBL1052130
(1)
|
0 / 0 |
P09619 | Platelet-derived growth factor receptor beta | Pdgfr | CHEMBL289277 |
CHEMBL865162
(1)
|
5 / 1 |
P16234 | Platelet-derived growth factor receptor alpha | Pdgfr | CHEMBL289277 |
CHEMBL865162
(1)
|
2 / 1 |
Q9HCP0 | Casein kinase I isoform gamma-1 | Ck1 | CHEMBL289277 |
CHEMBL1051274
(1)
|
0 / 0 |
P48730 | Casein kinase I isoform delta | Ck1 | CHEMBL289277 |
CHEMBL1051274
(1)
|
1 / 0 |
P49674 | Casein kinase I isoform epsilon | Ck1 | CHEMBL289277 |
CHEMBL1051274
(1)
|
0 / 0 |
P78368 | Casein kinase I isoform gamma-2 | Ck1 | CHEMBL289277 |
CHEMBL1051274
(1)
|
0 / 0 |
P48729 | Casein kinase I isoform alpha | Ck1 | CHEMBL289277 |
CHEMBL1051274
(1)
|
0 / 0 |
compound | gene | gene name | gene description | interaction | interaction type | form |
reference
pmid |
---|---|---|---|---|---|---|---|
D004642 | 58 |
ACTA1
ACTA ASMA CFTD CFTD1 CFTDM MPFD NEM1 NEM2 NEM3 |
actin, alpha 1, skeletal muscle | Emodin results in decreased expression of ACTA1 mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 196 |
AHR
bHLHe76 |
aryl hydrocarbon receptor | Emodin binds to and results in increased activity of AHR protein |
affects binding
/ increases activity |
protein |
14644660
|
D004642 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | [arsenic trioxide co-treated with IFNA2 protein co-treated with Docosahexaenoic Acids co-treated with Emodin] results in decreased expression of AKT1 protein |
affects cotreatment
/ decreases expression |
protein |
17077332
|
D004642 | 207 |
AKT1
AKT CWS6 PKB PKB-ALPHA PRKBA RAC RAC-ALPHA |
v-akt murine thymoma viral oncogene homolog 1 (EC:2.7.11.1) | Emodin results in decreased expression of AKT1 mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 472 |
ATM
AT1 ATA ATC ATD ATDC ATE TEL1 TELO1 |
ataxia telangiectasia mutated (EC:2.7.11.1) | Emodin results in increased expression of ATM mRNA |
increases expression
|
mRNA |
16045814
|
D004642 | 472 |
ATM
AT1 ATA ATC ATD ATDC ATE TEL1 TELO1 |
ataxia telangiectasia mutated (EC:2.7.11.1) | Emodin results in increased phosphorylation of ATM protein |
increases phosphorylation
|
protein |
20855424
|
D004642 | 9529 |
BAG5
BAG-5 |
BCL2-associated athanogene 5 | Emodin results in decreased expression of BAG5 mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 51283 |
BFAR
BAR RNF47 |
bifunctional apoptosis regulator | Emodin results in decreased expression of BFAR mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 821 |
CANX
CNX IP90 P90 |
calnexin | Emodin results in decreased expression of CANX mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 9133 |
CCNB2
HsT17299 |
cyclin B2 | Emodin results in decreased expression of CCNB2 mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 8621 |
CDK13
CDC2L CDC2L5 CHED hCDK13 |
cyclin-dependent kinase 13 (EC:2.7.11.23 2.7.11.22) | Emodin results in decreased expression of CDK13 mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 1019 |
CDK4
CMM3 PSK-J3 |
cyclin-dependent kinase 4 (EC:2.7.11.22) | Emodin results in decreased expression of CDK4 mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 1951 |
CELSR3
CDHF11 EGFL1 FMI1 HFMI1 MEGF2 RESDA1 |
cadherin, EGF LAG seven-pass G-type receptor 3 | Emodin results in decreased expression of CELSR3 mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 10987 |
COPS5
CSN5 JAB1 MOV-34 SGN5 |
COP9 signalosome subunit 5 | [arsenic trioxide co-treated with IFNA2 protein co-treated with Docosahexaenoic Acids co-treated with Emodin] results in decreased expression of COPS5 protein |
affects cotreatment
/ decreases expression |
protein |
17077332
|
D004642 | 1509 |
CTSD
CLN10 CPSD |
cathepsin D (EC:3.4.23.5) | Emodin results in decreased expression of CTSD mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Emodin inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of CYP1A1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
17012224
|
D004642 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Emodin results in increased expression of CYP1A1 mRNA |
increases expression
|
mRNA |
11502733
|
D004642 | 1543 |
CYP1A1
AHH AHRR CP11 CYP1 P1-450 P450-C P450DX |
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) | Emodin results in increased expression of CYP1A1 protein |
increases expression
|
protein |
11502733
14644660 |
D004642 | 1545 |
CYP1B1
CP1B CYPIB1 GLC3A P4501B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) | Emodin results in increased expression of CYP1B1 mRNA |
increases expression
|
mRNA |
11502733
14990334 |
D004642 | 1545 |
CYP1B1
CP1B CYPIB1 GLC3A P4501B1 |
cytochrome P450, family 1, subfamily B, polypeptide 1 (EC:1.14.14.1) | Emodin results in increased expression of CYP1B1 protein |
increases expression
|
protein |
11502733
|
D004642 | 1719 |
DHFR
DHFRP1 DYR |
dihydrofolate reductase (EC:1.5.1.3) | Emodin results in decreased expression of DHFR mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 3337 |
DNAJB1
HSPF1 Hdj1 Hsp40 RSPH16B Sis1 |
DnaJ (Hsp40) homolog, subfamily B, member 1 | Emodin results in increased expression of DNAJB1 mRNA |
increases expression
|
mRNA |
16045814
|
D004642 | 1875 |
E2F5
E2F-5 |
E2F transcription factor 5, p130-binding | Emodin results in increased expression of E2F5 mRNA |
increases expression
|
mRNA |
16045814
|
D004642 | 9538 |
EI24
EPG4 PIG8 TP53I8 |
etoposide induced 2.4 | Emodin results in increased expression of EI24 mRNA |
increases expression
|
mRNA |
16045814
|
D004642 | 1967 |
EIF2B1
EIF2B EIF2BA |
eukaryotic translation initiation factor 2B, subunit 1 alpha, 26kDa | Emodin results in decreased expression of EIF2B1 mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 2099 |
ESR1
ER ESR ESRA ESTRR Era NR3A1 |
estrogen receptor 1 | Emodin results in increased activity of ESR1 protein |
increases activity
|
protein |
19161236
|
D004642 | 2100 |
ESR2
ER-BETA ESR-BETA ESRB ESTRB Erb NR3A2 |
estrogen receptor 2 (ER beta) | Emodin results in increased activity of ESR2 protein |
increases activity
|
protein |
19161236
|
D004642 | 2308 |
FOXO1
FKH1 FKHR FOXO1A |
forkhead box O1 | Emodin results in increased expression of FOXO1 mRNA |
increases expression
|
mRNA |
16045814
|
D004642 | 2620 |
GAS2
|
growth arrest-specific 2 | Emodin results in increased expression of GAS2 mRNA |
increases expression
|
mRNA |
16045814
|
D004642 | 2876 |
GPX1
GPXD GSHPX1 |
glutathione peroxidase 1 (EC:1.11.1.9) | Emodin results in increased expression of GPX1 mRNA |
increases expression
|
mRNA |
16045814
|
D004642 | 2947 |
GSTM3
GST5 GSTB GSTM3-3 GTM3 |
glutathione S-transferase mu 3 (brain) (EC:2.5.1.18) | Emodin results in decreased expression of GSTM3 mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 2950 |
GSTP1
DFN7 FAEES3 GST3 GSTP PI |
glutathione S-transferase pi 1 (EC:2.5.1.18) | Emodin inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of GSTP1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
15313406
|
D004642 | 2950 |
GSTP1
DFN7 FAEES3 GST3 GSTP PI |
glutathione S-transferase pi 1 (EC:2.5.1.18) | Emodin inhibits the reaction [TNF protein results in increased expression of GSTP1 mRNA] |
decreases reaction
/ increases expression |
mRNA |
15313406
|
D004642 | 3014 |
H2AFX
H2A.X H2A/X H2AX |
H2A histone family, member X | Emodin results in increased expression of H2AFX protein modified form |
increases expression
|
protein |
20855424
|
D004642 | 3014 |
H2AFX
H2A.X H2A/X H2AX |
H2A histone family, member X | TOP2A affects the reaction [Emodin results in increased expression of H2AFX protein modified form] |
affects reaction
/ increases expression |
protein |
20855424
|
D004642 | 3440 |
IFNA2
IFN-alphaA IFNA IFNA2B INFA2 |
interferon, alpha 2 | [arsenic trioxide co-treated with IFNA2 protein co-treated with Docosahexaenoic Acids co-treated with Emodin] results in decreased expression of AKT1 protein |
affects cotreatment
/ decreases expression |
protein |
17077332
|
D004642 | 3440 |
IFNA2
IFN-alphaA IFNA IFNA2B INFA2 |
interferon, alpha 2 | [arsenic trioxide co-treated with IFNA2 protein co-treated with Docosahexaenoic Acids co-treated with Emodin] results in decreased expression of COPS5 protein |
affects cotreatment
/ decreases expression |
protein |
17077332
|
D004642 | 3440 |
IFNA2
IFN-alphaA IFNA IFNA2B INFA2 |
interferon, alpha 2 | [arsenic trioxide co-treated with IFNA2 protein co-treated with Docosahexaenoic Acids co-treated with Emodin] results in decreased expression of JUND protein |
affects cotreatment
/ decreases expression |
protein |
17077332
|
D004642 | 3708 |
ITPR1
INSP3R1 IP3R IP3R1 SCA15 SCA16 SCA29 |
inositol 1,4,5-trisphosphate receptor, type 1 | Emodin results in decreased expression of ITPR1 mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 3727 |
JUND
AP-1 |
jun D proto-oncogene | [arsenic trioxide co-treated with IFNA2 protein co-treated with Docosahexaenoic Acids co-treated with Emodin] results in decreased expression of JUND protein |
affects cotreatment
/ decreases expression |
protein |
17077332
|
D004642 | 3880 |
KRT19
CK19 K19 K1CS |
keratin 19 | Emodin results in decreased expression of KRT19 mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 23499 |
MACF1
ABP620 ACF7 MACF OFC4 |
microtubule-actin crosslinking factor 1 | Emodin results in decreased expression of MACF1 mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 1432 |
MAPK14
CSBP CSBP1 CSBP2 CSPB1 EXIP Mxi2 PRKM14 PRKM15 RK SAPK2A p38 p38ALPHA |
mitogen-activated protein kinase 14 (EC:2.7.11.24) | Acetylcysteine inhibits the reaction [Emodin promotes the reaction [arsenic trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein]] |
decreases reaction
/ increases activity / increases phosphorylation / increases reaction |
protein |
14729614
|
D004642 | 1432 |
MAPK14
CSBP CSBP1 CSBP2 CSPB1 EXIP Mxi2 PRKM14 PRKM15 RK SAPK2A p38 p38ALPHA |
mitogen-activated protein kinase 14 (EC:2.7.11.24) | Emodin promotes the reaction [arsenic trioxide results in increased phosphorylation of and results in increased activity of MAPK14 protein] |
increases activity
/ increases phosphorylation / increases reaction |
protein |
14729614
|
D004642 | 4137 |
MAPT
DDPAC FTDP-17 MAPTL MSTD MTBT1 MTBT2 PPND TAU |
microtubule-associated protein tau | Emodin results in decreased expression of MAPT mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 4792 |
NFKBIA
IKBA MAD-3 NFKBI |
nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha | Emodin results in increased expression of NFKBIA mRNA |
increases expression
|
mRNA |
16045814
|
D004642 | 5082 |
PDCL
PhLP |
phosducin-like | Emodin results in decreased expression of PDCL mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 5289 |
PIK3C3
VPS34 hVps34 |
phosphatidylinositol 3-kinase, catalytic subunit type 3 (EC:2.7.1.137) | Emodin results in increased expression of PIK3C3 mRNA |
increases expression
|
mRNA |
16045814
|
D004642 | 8493 |
PPM1D
PP2C-DELTA WIP1 |
protein phosphatase, Mg2+/Mn2+ dependent, 1D (EC:3.1.3.16) | Emodin results in increased expression of PPM1D mRNA |
increases expression
|
mRNA |
16045814
|
D004642 | 9588 |
PRDX6
1-Cys AOP2 NSGPx PRX aiPLA2 p29 |
peroxiredoxin 6 (EC:1.11.1.9 1.11.1.15) | Emodin results in increased expression of PRDX6 mRNA |
increases expression
|
mRNA |
16045814
|
D004642 | 5580 |
PRKCD
MAY1 PKCD nPKC-delta |
protein kinase C, delta (EC:2.7.10.2 2.7.11.13) | Emodin results in decreased expression of PRKCD mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 51495 |
PTPLAD1
B-IND1 HACD3 HSPC121 |
protein tyrosine phosphatase-like A domain containing 1 (EC:4.2.1.134) | Emodin results in decreased expression of PTPLAD1 mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 5894 |
RAF1
CRAF NS5 Raf-1 c-Raf |
v-raf-1 murine leukemia viral oncogene homolog 1 (EC:2.7.11.1) | Emodin results in decreased expression of RAF1 mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 5925 |
RB1
OSRC RB p105-Rb pRb pp110 |
retinoblastoma 1 | Emodin results in decreased expression of RB1 mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 5955 |
RCN2
E6BP ERC-55 ERC55 TCBP49 |
reticulocalbin 2, EF-hand calcium binding domain | Emodin results in increased expression of RCN2 mRNA |
increases expression
|
mRNA |
16045814
|
D004642 | 387 |
RHOA
ARH12 ARHA RHO12 RHOH12 |
ras homolog family member A | Emodin results in decreased expression of RHOA mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 6093 |
ROCK1
P160ROCK ROCK-I |
Rho-associated, coiled-coil containing protein kinase 1 (EC:2.7.11.1) | Emodin results in decreased expression of ROCK1 mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 9475 |
ROCK2
ROCK-II |
Rho-associated, coiled-coil containing protein kinase 2 (EC:2.7.11.1) | Emodin results in decreased expression of ROCK2 mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 10055 |
SAE1
AOS1 HSPC140 SUA1 UBLE1A |
SUMO1 activating enzyme subunit 1 | Emodin results in decreased expression of SAE1 mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 5054 |
SERPINE1
PAI PAI-1 PAI1 PLANH1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Emodin inhibits the reaction [TNF protein results in increased secretion of SERPINE1 protein]] |
decreases reaction
/ increases reaction / increases secretion |
protein |
14534369
|
D004642 | 5054 |
SERPINE1
PAI PAI-1 PAI1 PLANH1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | Emodin inhibits the reaction [TNF protein results in increased secretion of SERPINE1 protein] |
decreases reaction
/ increases secretion |
protein |
14534369
|
D004642 | 5054 |
SERPINE1
PAI PAI-1 PAI1 PLANH1 |
serpin peptidase inhibitor, clade E (nexin, plasminogen activator inhibitor type 1), member 1 | Emodin promotes the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [TNF protein results in increased secretion of SERPINE1 protein]] |
decreases reaction
/ increases reaction / increases secretion |
protein |
14534369
|
D004642 | 6489 |
ST8SIA1
GD3S SIAT8 SIAT8-A SIAT8A ST8SiaI |
ST8 alpha-N-acetyl-neuraminide alpha-2,8-sialyltransferase 1 (EC:2.4.99.8) | Emodin results in increased expression of ST8SIA1 mRNA |
increases expression
|
mRNA |
16045814
|
D004642 | 10963 |
STIP1
HOP IEF-SSP-3521 P60 STI1 STI1L |
stress-induced-phosphoprotein 1 | Emodin results in decreased expression of STIP1 mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 55578 |
SUPT20H
C13 C13orf19 FAM48A P38IP SPT20 |
suppressor of Ty 20 homolog (S. cerevisiae) | Emodin results in increased expression of SUPT20H mRNA |
increases expression
|
mRNA |
16045814
|
D004642 | 51347 |
TAOK3
DPK JIK MAP3K18 |
TAO kinase 3 (EC:2.7.11.1) | Emodin results in decreased expression of TAOK3 mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 6903 |
TBCC
CFC |
tubulin folding cofactor C | Emodin results in decreased expression of TBCC mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one promotes the reaction [Emodin inhibits the reaction [TNF protein results in increased secretion of SERPINE1 protein]] |
decreases reaction
/ increases reaction / increases secretion |
protein |
14534369
|
D004642 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Emodin inhibits the reaction [TNF protein results in increased expression of GSTP1 mRNA] |
decreases reaction
/ increases expression |
protein |
15313406
|
D004642 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Emodin inhibits the reaction [TNF protein results in increased secretion of SERPINE1 protein] |
decreases reaction
/ increases secretion |
protein |
14534369
|
D004642 | 7124 |
TNF
DIF TNF-alpha TNFA TNFSF2 |
tumor necrosis factor | Emodin promotes the reaction [2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [TNF protein results in increased secretion of SERPINE1 protein]] |
decreases reaction
/ increases reaction / increases secretion |
protein |
14534369
|
D004642 | 7153 |
TOP2A
TOP2 TP2A |
topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) | Emodin inhibits the reaction [TOP2A results in increased hydrolysis of Adenosine Triphosphate] |
decreases reaction
/ increases hydrolysis |
20855424
|
|
D004642 | 7153 |
TOP2A
TOP2 TP2A |
topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) | Emodin results in increased activity of TOP2A protein |
increases activity
|
protein |
20855424
|
D004642 | 7153 |
TOP2A
TOP2 TP2A |
topoisomerase (DNA) II alpha 170kDa (EC:5.99.1.3) | TOP2A affects the reaction [Emodin results in increased expression of H2AFX protein modified form] |
affects reaction
/ increases expression |
20855424
|
|
D004642 | 7186 |
TRAF2
MGC:45012 TRAP TRAP3 |
TNF receptor-associated factor 2 | Emodin results in increased expression of TRAF2 mRNA |
increases expression
|
mRNA |
16045814
|
D004642 | 10381 |
TUBB3
CDCBM CDCBM1 CFEOM3A TUBB4 beta-4 |
tubulin, beta 3 class III | Emodin results in decreased expression of TUBB3 mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 54957 |
TXNL4B
DLP Dim2 |
thioredoxin-like 4B | Emodin results in decreased expression of TXNL4B mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 7296 |
TXNRD1
GRIM-12 TR TR1 TRXR1 TXNR |
thioredoxin reductase 1 (EC:1.8.1.9) | Emodin results in decreased expression of TXNRD1 mRNA |
decreases expression
|
mRNA |
16045814
|
D004642 | 54658 |
UGT1A1
BILIQTL1 GNT1 HUG-BR1 UDPGT UDPGT_1-1 UGT1 UGT1A |
UDP glucuronosyltransferase 1 family, polypeptide A1 (EC:2.4.1.17) | UGT1A1 protein results in increased glucuronidation of Emodin |
increases glucuronidation
|
protein |
14557274
|
D004642 | 54575 |
UGT1A10
UDPGT UGT-1J UGT1-10 UGT1.10 UGT1J |
UDP glucuronosyltransferase 1 family, polypeptide A10 (EC:2.4.1.17) | UGT1A10 protein results in increased glucuronidation of Emodin |
increases glucuronidation
|
protein |
14557274
|
D004642 | 54577 |
UGT1A7
UDPGT UDPGT_1-7 UGT-1G UGT1-07 UGT1.7 UGT1G |
UDP glucuronosyltransferase 1 family, polypeptide A7 (EC:2.4.1.17) | UGT1A7 protein results in increased glucuronidation of Emodin |
increases glucuronidation
|
protein |
14557274
|
D004642 | 54576 |
UGT1A8
UDPGT UDPGT_1-8 UGT-1H UGT1-08 UGT1.8 UGT1A8S UGT1H |
UDP glucuronosyltransferase 1 family, polypeptide A8 (EC:2.4.1.17) | UGT1A8 protein results in increased glucuronidation of Emodin |
increases glucuronidation
|
protein |
14557274
|
D004642 | 54600 |
UGT1A9
HLUGP4 LUGP4 UDPGT UDPGT_1-9 UGT-1I UGT1-09 UGT1-9 UGT1.9 UGT1AI UGT1I |
UDP glucuronosyltransferase 1 family, polypeptide A9 (EC:2.4.1.17) | UGT1A9 protein results in increased glucuronidation of Emodin |
increases glucuronidation
|
protein |
14557274
|
D004642 | 7366 |
UGT2B15
HLUG4 UDPGT_2B8 UDPGT2B15 UDPGTH3 UGT2B8 |
UDP glucuronosyltransferase 2 family, polypeptide B15 (EC:2.4.1.17) | UGT2B15 protein results in increased metabolism of Emodin |
increases metabolic processing
|
protein |
7835232
|
D004642 | 7416 |
VDAC1
PORIN VDAC-1 |
voltage-dependent anion channel 1 | Emodin results in decreased expression of VDAC1 mRNA |
decreases expression
|
mRNA |
16045814
|
OMIM | preferred title | UniProt |
---|---|---|
#300438 | 17-beta-hydroxysteroid dehydrogenase x deficiency |
Q99714
|
#202300 | Adrenocortical carcinoma, hereditary; adcc |
P04637
|
#615224 | Advanced sleep phase syndrome, familial, 2; fasps2 |
P48730
|
#300068 | Androgen insensitivity syndrome; ais |
P10275
|
#312300 | Androgen insensitivity, partial; pais |
P10275
|
#614740 | Basal cell carcinoma, susceptibility to, 7; bcc7 |
P04637
|
#615007 | Basal ganglia calcification, idiopathic, 4; ibgc4 |
P09619
|
#601816 | Bilirubin, serum level of, quantitative trait locus 1; biliqtl1 |
P22309
|
#609821 | Bleeding disorder, platelet-type, 8; bdplt8 |
Q9H244
|
#210900 | Bloom syndrome; blm |
P54132
|
%606641 | Body mass index; bmi |
P37231
|
#114480 | Breast cancer |
P31749
P42336 |
#615279 | Cardiofaciocutaneous syndrome 3; cfc3 |
Q02750
|
#115200 | Cardiomyopathy, dilated, 1a; cmd1a |
P02545
|
#212112 | Cardiomyopathy, dilated, with hypergonadotropic hypogonadism |
P02545
|
#609338 | Carotid intimal medial thickness 1 |
P37231
|
#605588 | Charcot-marie-tooth disease, axonal, type 2b1; cmt2b1 |
P02545
|
#114500 | Colorectal cancer; crc |
P31749
P42336 |
#612918 | Congenital lipomatous overgrowth, vascular malformations, and epidermal nevi |
P42336
|
#615108 | Cowden syndrome 5; cws5 |
P42336
|
#615109 | Cowden syndrome 6; cws6 |
P31749
|
#218800 | Crigler-najjar syndrome, type i |
P22309
P22310 |
#606785 | Crigler-najjar syndrome, type ii |
P22309
P22310 |
#162800 | Cyclic neutropenia |
P08246
|
#609535 | Drug metabolism, poor, cyp2c19-related |
P33261
|
#608902 | Drug metabolism, poor, cyp2d6-related |
P10635
|
#181350 | Emery-dreifuss muscular dystrophy 2, autosomal dominant; edmd2 |
P02545
|
#133239 | Esophageal cancer |
P04637
|
#615363 | Estrogen resistance; estrr |
P03372
|
#612219 | Ewing sarcoma; es |
P11308
|
#600274 | Frontotemporal dementia; ftd |
P10636
|
#606764 | Gastrointestinal stromal tumor; gist |
P16234
|
#143500 | Gilbert syndrome |
P22309
P22310 |
#137800 | Glioma susceptibility 1; glm1 |
P37231
|
#605130 | Hairy elbows, short stature, facial dysmorphism, and developmental delay |
Q03164
|
#610140 | Heart-hand syndrome, slovenian type |
P02545
|
#114550 | Hepatocellular carcinoma |
P42336
|
#176670 | Hutchinson-gilford progeria syndrome; hgps |
P02545
|
#237900 | Hyperbilirubinemia, transient familial neonatal; hblrtfn |
P22309
|
#607685 | Hypereosinophilic syndrome, idiopathic; hes |
P16234
|
#145000 | Hyperparathyroidism 1; hrpt1 |
O00255
|
#603373 | Hyperthyroidism, familial gestational |
P16473
|
#609152 | Hyperthyroidism, nonautoimmune |
P16473
|
#275200 | Hypothyroidism, congenital, nongoitrous, 1; chng1 |
P16473
|
#607785 | Juvenile myelomonocytic leukemia; jmml |
P09619
|
#182000 | Keratosis, seborrheic |
P42336
|
#601626 | Leukemia, acute myeloid; aml |
P09619
|
#151623 | Li-fraumeni syndrome 1; lfs1 |
P04637
|
#151660 | Lipodystrophy, familial partial, type 2; fpld2 |
P02545
|
#604367 | Lipodystrophy, familial partial, type 3; fpld3 |
P37231
|
#613688 | Long qt syndrome 2; lqt2 |
Q12809
|
#211980 | Lung cancer |
P04637
|
#248370 | Mandibuloacral dysplasia with type a lipodystrophy; mada |
P02545
|
#602501 | Megalencephaly-capillary malformation-polymicrogyria syndrome; mcap |
P42336
|
#603387 | Megalencephaly-polymicrogyria-polydactyly-hydrocephalus syndrome; mpph |
P42336
|
#614104 | Mental retardation, autosomal dominant 7; mrd7 |
Q13627
|
#300705 | Mental retardation, x-linked 17; mrx17 |
Q99714
|
#300220 | Mental retardation, x-linked, syndromic 10; mrxs10 |
Q99714
|
#131100 | Multiple endocrine neoplasia, type i; men1 |
O00255
|
#613205 | Muscular dystrophy, congenital, lmna-related |
P02545
|
#159001 | Muscular dystrophy, limb-girdle, type 1b; lgmd1b |
P02545
|
#607948 | Mycobacterium tuberculosis, susceptibility to |
P11473
|
#131440 | Myeloproliferative disorder, chronic, with eosinophilia |
P09619
|
#228550 | Myofibromatosis, infantile, 1; imf1 |
P09619
|
#160900 | Myotonic dystrophy 1; dm1 |
Q9NR56
|
#202700 | Neutropenia, severe congenital, 1, autosomal dominant; scn1 |
P08246
|
#257220 | Niemann-pick disease, type c1; npc1 |
O15118
|
#601665 | Obesity |
P37231
|
#167000 | Ovarian cancer |
P42336
|
#260500 | Papilloma of choroid plexus; cpp |
P04637
|
#260540 | Parkinson-dementia syndrome |
P10636
|
#172700 | Pick disease of brain |
P10636
|
#601399 | Platelet disorder, familial, with associated myeloid malignancy |
Q01196
|
#176920 | Proteus syndrome |
P31749
|
#275210 | Restrictive dermopathy, lethal |
P02545
|
#604906 | Schizophrenia 9; sczd9 |
P49798
|
#181500 | Schizophrenia; sczd |
P49798
|
#609620 | Short qt syndrome 1; sqt1 |
Q12809
|
#313200 | Spinal and bulbar muscular atrophy, x-linked 1; smax1 |
P10275
|
#607250 | Spinocerebellar ataxia, autosomal recessive, with axonal neuropathy; scan1 |
Q9NUW8
|
#275355 | Squamous cell carcinoma, head and neck; hnscc |
P04637
|
#601104 | Supranuclear palsy, progressive, 1; psnp1 |
P10636
|
#187950 | Thrombocythemia 1; thcyt1 |
P40225
|
#188570 | Thyroid hormone resistance, generalized, autosomal dominant; grth |
P10828
|
#274300 | Thyroid hormone resistance, generalized, autosomal recessive; grth |
P10828
|
#145650 | Thyroid hormone resistance, selective pituitary; prth |
P10828
|
#277440 | Vitamin d-dependent rickets, type 2a; vddr2a |
P11473
|
#278750 | Xeroderma pigmentosum, variant type; xpv |
Q9Y253
|
KEGG | disease name | UniProt |
---|---|---|
H00033 | Adrenal carcinoma |
O00255
(related)
P04637 (related) |
H00034 | Carcinoid |
O00255
(related)
|
H00045 | Malignant islet cell carcinoma |
O00255
(related)
|
H00246 | Primary hyperparathyroidism |
O00255
(related)
|
H01102 | Pituitary adenomas |
O00255
(related)
|
H00136 | Niemann-Pick disease type C (NPC) |
O15118
(related)
|
H00264 | Charcot-Marie-Tooth disease (CMT) |
P02545
(related)
|
H00294 | Dilated cardiomyopathy (DCM) |
P02545
(related)
|
H00420 | Familial partial lipodystrophy (FPL) |
P02545
(related)
P37231 (related) |
H00563 | Emery-Dreifuss muscular dystrophy |
P02545
(related)
|
H00590 | Congenital muscular dystrophies (CMD/MDC) |
P02545
(related)
|
H00593 | Limb-girdle muscular dystrophy (LGMD) |
P02545
(related)
|
H00601 | Hutchinson-Gilford progeria syndrome |
P02545
(related)
|
H00663 | Restrictive dermopathy |
P02545
(related)
|
H00665 | Mandibuloacral dysplasia |
P02545
(related)
|
H01216 | Left ventricular noncompaction (LVNC) |
P02545
(related)
|
H00026 | Endometrial Cancer |
P03372
(marker)
P04637 (related) Q92731 (marker) |
H00599 | 46,XX disorders of sex development (Disorders related to androgen excess) |
P04150
(related)
|
H00004 | Chronic myeloid leukemia (CML) |
P04637
(related)
Q01196 (related) |
H00005 | Chronic lymphocytic leukemia (CLL) |
P04637
(related)
|
H00006 | Hairy-cell leukemia |
P04637
(related)
|
H00008 | Burkitt lymphoma |
P04637
(related)
|
H00009 | Adult T-cell leukemia |
P04637
(related)
|
H00010 | Multiple myeloma |
P04637
(related)
|
H00013 | Small cell lung cancer |
P04637
(related)
|
H00014 | Non-small cell lung cancer |
P04637
(related)
|
H00015 | Malignant pleural mesothelioma |
P04637
(related)
|
H00016 | Oral cancer |
P04637
(related)
P04637 (marker) |
H00017 | Esophageal cancer |
P04637
(related)
P04637 (marker) |
H00018 | Gastric cancer |
P04637
(related)
|
H00019 | Pancreatic cancer |
P04637
(related)
P04637 (marker) |
H00020 | Colorectal cancer |
P04637
(related)
P04637 (marker) |
H00022 | Bladder cancer |
P04637
(related)
|
H00025 | Penile cancer |
P04637
(related)
P04637 (marker) |
H00027 | Ovarian cancer |
P04637
(related)
P42336 (related) |
H00028 | Choriocarcinoma |
P04637
(related)
|
H00029 | Vulvar cancer |
P04637
(related)
|
H00031 | Breast cancer |
P04637
(related)
|
H00032 | Thyroid cancer |
P04637
(related)
P37231 (related) |
H00036 | Osteosarcoma |
P04637
(related)
P08684 (marker) P15311 (marker) |
H00038 | Malignant melanoma |
P04637
(related)
|
H00039 | Basal cell carcinoma |
P04637
(related)
|
H00040 | Squamous cell carcinoma |
P04637
(related)
|
H00041 | Kaposi's sarcoma |
P04637
(related)
|
H00042 | Glioma |
P04637
(related)
P04637 (marker) P09619 (related) P16234 (related) |
H00044 | Cancer of the anal canal |
P04637
(related)
|
H00046 | Cholangiocarcinoma |
P04637
(related)
|
H00047 | Gallbladder cancer |
P04637
(related)
|
H00048 | Hepatocellular carcinoma |
P04637
(related)
|
H00055 | Laryngeal cancer |
P04637
(related)
P04637 (marker) |
H00881 | Li-Fraumeni syndrome |
P04637
(related)
|
H01007 | Choroid plexus papilloma |
P04637
(related)
|
H00021 | Renal cell carcinoma |
P04637
(marker)
|
H00093 | Combined immunodeficiencies (CIDs) |
P06239
(related)
|
H00100 | Neutropenic disorders |
P08246
(related)
|
H00024 | Prostate cancer |
P10275
(related)
P11308 (related) |
H00062 | Spinal and bulbar muscular atrophy (SBMA) |
P10275
(related)
|
H00608 | 46,XY disorders of sex development (Disorders in androgen synthesis or action) |
P10275
(related)
|
H00609 | 46,XY disorders of sex development (Other) |
P10275
(related)
|
H00058 | Amyotrophic lateral sclerosis (ALS) |
P10636
(related)
|
H00077 | Progressive supranuclear palsy (PSP) |
P10636
(related)
|
H00078 | Frontotemporal lobar degeneration (FTLD) |
P10636
(related)
|
H00249 | Thyroid hormone resistance syndrome |
P10828
(related)
|
H00035 | Ewing's sarcoma |
P11308
(related)
|
H00342 | Tuberculosis |
P11473
(related)
|
H00784 | Localized autosomal recessive hypotrichosis |
P11473
(related)
|
H01143 | Vitamin D-dependent rickets |
P11473
(related)
|
H01205 | Coumarin resistance |
P11712
(related)
|
H00250 | Congenital nongoitrous hypothyroidism (CHNG) |
P16473
(related)
|
H01269 | Congenital hyperthyroidism |
P16473
(related)
|
H00208 | Hyperbilirubinemia |
P22309
(related)
|
H00539 | PTEN hamartoma tumor syndrome (PHTS) |
P31749
(related)
|
H01171 | Poor drug metabolism (PM) |
P33261
(related)
|
H00409 | Type II diabetes mellitus |
P37231
(related)
|
H00227 | Congenital amegakaryocytic thrombocytopenia (CAMT) |
P40225
(marker)
|
H00606 | Early infantile epileptic encephalopathy |
P53779
(related)
|
H00094 | DNA repair defects |
P54132
(related)
|
H00296 | Defects in RecQ helicases |
P54132
(related)
|
H00001 | Acute lymphoblastic leukemia (ALL) (precursor B lymphoblastic leukemia) |
Q01196
(related)
Q01196 (marker) Q03164 (related) Q03164 (marker) |
H00003 | Acute myeloid leukemia (AML) |
Q01196
(related)
Q01196 (marker) Q13951 (marker) |
H00978 | Thrombocytopenia (THC) |
Q01196
(related)
|
H00523 | Noonan syndrome and related disorders |
Q02750
(related)
|
H00002 | Acute lymphoblastic leukemia (ALL) (precursor T lymphoblastic leukemia) |
Q03164
(related)
|
H00720 | Long QT syndrome |
Q12809
(related)
|
H00725 | Short QT syndrome |
Q12809
(related)
|
H00480 | Non-syndromic X-linked mental retardation |
Q99714
(related)
|
H00658 | Syndromic X-linked mental retardation |
Q99714
(related)
|
H00925 | 2-Methyl-3-hydroxybutyryl-CoA dehydrogenase (MHBD) deficiency |
Q99714
(related)
|
H01235 | Bleeding disorder platelet-type |
Q9H244
(related)
|
H00063 | Spinocerebellar ataxia (SCA) |
Q9NUW8
(related)
|
H00403 | Disorders of nucleotide excision repair |
Q9Y253
(related)
|
MeSH disease | OMIM | compound | disease name | evidence type |
reference
pmid |
---|---|---|---|---|---|
D001249 | D004642 | Asthma |
therapeutic
|
22484343
|
|
D004802 | D004642 | Eosinophilia |
therapeutic
|
22484343
|
|
D005317 | D004642 | Fetal Growth Retardation |
marker/mechanism
|
22609528
|
|
D005327 | D004642 | Fetal Resorption |
marker/mechanism
|
22609528
|
|
D020567 | D004642 | Fetal Weight |
marker/mechanism
|
22609528
|
|
D005355 | D004642 | Fibrosis |
therapeutic
|
19474275
|
|
D015459 | D004642 | Leukemia-Lymphoma, Adult T-Cell |
therapeutic
|
17077332
|
|
D008106 | D004642 | Liver Cirrhosis, Experimental |
therapeutic
|
15288473
|
|
D010922 | D004642 | Placenta Diseases |
marker/mechanism
|
22609528
|